Article

Genetic predisposition for atopy and allergic rhinitis in the Singapore Chinese population.

Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Asia Pacific allergy 10/2011; 1(3):152-6. DOI:10.5415/apallergy.2011.1.3.152 pp.152-6
Source: PubMed

ABSTRACT The prevalence of allergic diseases is high globally, but especially in developed countries, with one in five to one in four individuals affected worldwide. The World Health Organization's "Allergic Rhinitis and its Impact on Asthma 2008 Update" guidelines stated explicitly that over 600 million patients from all countries, all ethnic groups and all ages suffer from allergic rhinitis (AR). There are clear evidences to support the concept that allergic diseases are influenced by genetic predisposition and environmental factors. The genetic basis of AR has been evaluated more intensively in the recent 10-20 years. Advances in technology and statistical methods, such as genome-wide association studies (GWAS) have enabled millions of single nucleotide polymorphisms (SNPs) to be genotyped at rapid pace and for less cost. However these studies have not yet answered the entire heritability profile of the disease. Additionally, environmental influences on these genetic variants cannot be discounted. Hence these allergic diseases must be evaluated as a complex interplay between genetic and environmental factors. This review focuses on the genetic basis of AR, with special emphasis on studies performed in Singapore. Candidate gene based studies and GWAS performed in Singapore cohorts have been discussed to suggest how these diseases could be understood better in a Singapore context which is still applicable to research in AR globally.

0 0
 · 
1 Bookmark
 · 
55 Views
  • Article: Epidemiology of allergic rhinitis and its associated risk factors in Singapore.
    [show abstract] [hide abstract]
    ABSTRACT: Few studies have evaluated the relationship between allergic rhinitis and risk factors in the environment which promote aeroallergenic exposures, but knowledge of these are of practical importance from the point of view of community prevention. A cross-sectional population-based study of 2868 adults aged 20-74 years was carried out. Allergic rhinitis was defined as the self-reported presence, in the previous year, of usual nasal blockage and discharge apart from colds or the flu, provoked by allergens, with or without conjunctivitis. Allergic rhinitis was reported by 4.5% of the subjects. Higher crude prevalences were observed in males, younger adults, Indians compared to Chinese and Malays, those with higher socioeconomic status, and in three of five residential areas studied. Significant environmental factors included cockroach infestation, occupational exposure, past smoking habit, outdoor air pollution, and frequent heavy exposure to cooking fumes. Keeping pets, having rugs or carpets in the home, and passive exposure to tobacco smoke showed weak and statistically insignificant associations. There was no apparent association with use of mosquito coils or incense. The significant determinants after multivariate adjustment of all risk factors were age, race, flat size, area of residence, cockroach infestation, past smoking, and occupational and cooking fumes exposure. The study underscores the importance of environmental control of inhalational exposure to common allergens and irritants in the prevention of allergic rhinitis.
    International Journal of Epidemiology 07/1994; 23(3):553-8. · 6.41 Impact Factor
  • Article: Management of persistent allergic rhinitis in the tropics: Singapore experiences
    [show abstract] [hide abstract]
    ABSTRACT: Allergic rhinitis (AR) is a common manifestation of allergic diseases, affecting 10–25% of the world's population. In the tropics, the majority of AR is persistent. The year-round warm, humid climate is conducive for the proliferation of dust mites and moulds, two of the most common aeroallergens implicated in persistent allergic rhinitis (PAR). The management of AR includes patient education, allergen avoidance, pharmacological treatment, and specific immunotherapy. Patient education, especially regarding dust and mould exposure reduction, can be effective but is often under-utilized. Second generation, non-sedating H1-antihistamines rapidly relieve most nasal symptoms because they effectively block the histamine H1-receptors that trigger plasma exudation and oedema. Congestion is most effectively controlled by intranasal glucocorticosteroids (INSs), which are currently the most potent AR drug treatment. The beneficial effects of steroids depend on their long-term, multi-pathway anti-inflammatory effects, unlike H1-antihistamines, which directly block neural and vascular H1 receptors. However, especially in PAR, patients' compliance with INS therapy has a significant impact on treatment efficacy, because year-round treatment is required. Subcutaneous inhalant allergen immunotherapy (SCIT) is effective against a broad range of AR symptoms, and may be able to alter the natural course of allergy and prevent asthma onset. SCIT can significantly reduce the severity of allergic disease, including nasal obstruction, and decrease the need for anti-allergic drugs. Immunotherapy (IT) can also be given as sublingual drops (SLIT). Recent studies have shown the SLIT to be effective in reducing AR symptoms and medication use. Both types of IT require long-term patient compliance for successful treatment. Drug and IT interventions may not be economically feasible in certain patients. In conclusion, the type of AR most prevalent in the tropics is PAR, which must be treated year round. Improvement of educational programmes for the public and physicians alike seems to be the most effective treatment strategy.
    Clinical & Experimental Allergy Reviews. 07/2008; 8(2):37 - 44.
  • Article: Rhinitis as an independent risk factor for adult-onset asthma.
    [show abstract] [hide abstract]
    ABSTRACT: For many years, the association between asthma and rhinitis has primarily been attributed to a common allergic background. Recently, it has been suggested that asthma and rhinitis are associated in the absence of atopy. The nature of this association is not well known. The purpose of this study, which was performed in a large, longitudinal community population, was to determine the extent to which rhinitis is an independent risk factor for adult-onset asthma. We carried out a nested case-control study from the longitudinal cohort of the Tucson Epidemiologic Study of Obstructive Lung Diseases. One hundred seventy-three incident patients with physician-confirmed asthma were compared with 2177 subjects who reported no asthma or shortness of breath with wheezing. Potential risk factors, including the presence of rhinitis, were assessed before the onset of asthma (patients) or before the last completed survey (control subjects). Rhinitis was a significant risk factor for asthma (crude odds ratio, 4.13; 95% confidence interval, 2.88-5.92). After adjustment for years of follow-up, age, sex, atopic status, smoking status, and presence of chronic obstructive pulmonary disease, the magnitude of the association was reduced but still highly significant (adjusted odds ratio, 3.21; 95% confidence interval, 2.19-4.71). After stratification, rhinitis increased the risk of development of asthma by about 3 times both among atopic and nonatopic patients and by more than 5 times among patients in the highest IgE tertile. Patients with rhinitis with persistent and severe nasal symptoms and a personal history of physician-confirmed sinusitis had an additional increased risk of asthma development. We conclude that rhinitis is a significant risk factor for adult-onset asthma in both atopic and nonatopic subjects. The nature of the association between rhinitis and asthma is open to interpretation.
    Journal of Allergy and Clinical Immunology 04/2002; 109(3):419-25. · 11.00 Impact Factor

Full-text (2 Sources)

View
1 Download
Available from

Keywords

600 million patients
 
allergic diseases
 
Allergic Rhinitis
 
AR globally
 
Asthma 2008 Update
 
complex interplay
 
diseases
 
entire heritability profile
 
ethnic groups
 
four individuals
 
genetic basis
 
genetic predisposition
 
genetic variants
 
genome-wide association studies
 
millions
 
recent 10-20 years
 
Singapore cohorts
 
Singapore context
 
single nucleotide polymorphisms
 
World Health Organization's
 

De Yun Wang